Cargando…

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand

BACKGROUND: This study aims to determine the maximum price at which HIV vaccination is cost-effective in the Thai healthcare setting. It also aims to identify the relative importance of vaccine characteristics and risk behavior changes among vaccine recipients to determine how they affect this cost-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leelahavarong, Pattara, Teerawattananon, Yot, Werayingyong, Pitsaphun, Akaleephan, Chutima, Premsri, Nakorn, Namwat, Chawetsan, Peerapatanapokin, Wiwat, Tangcharoensathien, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224093/ https://www.ncbi.nlm.nih.gov/pubmed/21729309 http://dx.doi.org/10.1186/1471-2458-11-534

Ejemplares similares

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
por: Thavorncharoensap, Montarat, et al.
Publicado: (2013)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

Public health policies and health-care workers’ response to the COVID-19 pandemic, Thailand
por: Nittayasoot, Natthaprang, et al.
Publicado: (2021)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

Cost-effectiveness of models for prevention of vertical HIV transmission – voluntary counseling and testing and choices of drug regimen
por: Teerawattananon, Yot, et al.
Publicado: (2005)

An ex-ante economic evaluation of the Maternal and Child Health Voucher Scheme as a decision-making tool in Myanmar
por: Kingkaew, Pritaporn, et al.
Publicado: (2016)

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation
por: Pilasant, Songyot, et al.
Publicado: (2016)

Evolving HIV epidemics: the urgent need to refocus on populations with risk
por: Brown, Tim, et al.
Publicado: (2019)

Smoking prevalence and attributable deaths in Thailand: predicting outcomes of different tobacco control interventions
por: Aungkulanon, Suchunya, et al.
Publicado: (2019)

The impact of Thailand's public health response to the HIV epidemic 1984–2015: understanding the ingredients of success
por: Siraprapasiri, Taweesap, et al.
Publicado: (2016)

Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia
por: Afiatin,, et al.
Publicado: (2017)

An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand
por: Thiboonboon, Kittiphong, et al.
Publicado: (2015)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand
por: Jiamsiri, Suchada, et al.
Publicado: (2022)

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections
por: Kulpeng, Wantanee, et al.
Publicado: (2013)

Cost-utility analysis of the screening program for early oral cancer detection in Thailand
por: Kumdee, Chutima, et al.
Publicado: (2018)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
por: Kumluang, Suthasinee, et al.
Publicado: (2019)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
por: Yothasamut, Jomkwan, et al.
Publicado: (2010)

Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis
por: Meeyai, Aronrag, et al.
Publicado: (2015)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2018)

Health Related Quality of Life among Patients with Tuberculosis and HIV in Thailand
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2012)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2019)

Planning for future COVID-19 vaccine procurement
por: Teerawattananon, Yot, et al.
Publicado: (2022)

Cross-border movement of older patients: a descriptive study on health service use of Japanese retirees in Thailand
por: Miyashita, Yumiko, et al.
Publicado: (2017)

COVID-19 Vaccine Hesitancy Among Health Care Workers in Thailand: The Comparative Results of Two Cross-Sectional Online Surveys Before and After Vaccine Availability
por: Pheerapanyawaranun, Chatkamol, et al.
Publicado: (2022)

Erratum to: Cross-border movement of older patients: a descriptive study on health service use of Japanese retirees in Thailand
por: Miyashita, Yumiko, et al.
Publicado: (2017)

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: a rapid review and stakeholder consultation
por: Marshall, Aniqa Islam, et al.
Publicado: (2021)

Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand
por: Viriyathorn, Shaheda, et al.
Publicado: (2023)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review
por: Suphanchaimat, Rapeepong, et al.
Publicado: (2014)

Estimating recent HIV incidence among young men who have sex with men: Reinvigorating, validating and implementing Osmond's algorithm for behavioral imputation
por: van Griensven, Frits, et al.
Publicado: (2018)

How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic
por: Luangasanatip, Nantasit, et al.
Publicado: (2023)

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Prevalence of HPV infection among Thai schoolgirls in the north-eastern provinces in 2018: implications for HPV immunization policy
por: Vongpunsawad, Sompong, et al.
Publicado: (2023)

The impact of vaccine information and other factors on COVID-19 vaccine acceptance in the Thai population
por: Kosiyaporn, Hathairat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl8i20j9h2fksl0s3dplkj7d9f